MITAKA POINT SETTER
K991989 · Mitaka USA, Inc. · GWG · Aug 27, 1999 · Neurology
Device Facts
| Record ID | K991989 |
| Device Name | MITAKA POINT SETTER |
| Applicant | Mitaka USA, Inc. |
| Product Code | GWG · Neurology |
| Decision Date | Aug 27, 1999 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 882.1480 |
| Device Class | Class 2 |
Intended Use
The Mitaka Point Setter is intended for use by qualified surgeons for holding rigid and flexible endoscopes during diagnostic and therapeutic neurologic procedures.
Device Story
The Mitaka Point Setter is a manual/pneumatic surgical device designed to hold rigid and flexible endoscopes in a fixed position during neurologic procedures. It is operated by qualified surgeons in a clinical setting. By providing stable, hands-free support for the endoscope, the device assists the surgeon in maintaining visualization during diagnostic or therapeutic tasks, potentially reducing surgeon fatigue and improving procedural precision.
Technological Characteristics
Manual/pneumatic surgical device; constructed from materials commonly used in medical devices.
Indications for Use
Indicated for use by qualified surgeons to hold rigid and flexible endoscopes during diagnostic and therapeutic neurologic procedures.
Regulatory Classification
Identification
A neurological endoscope is an instrument with a light source used to view the inside of the ventricles of the brain.
Related Devices
- K990334 — KSEA ENDOSCOPE HOLDER · KARL STORZ Endoscopy-America, Inc. · Mar 22, 1999
- K984355 — POINT SETTER · Mitaka USA, Inc. · Apr 1, 1999
- K061292 — STATARIUS, MODEL 001 003 · Kinetic Surgical, LLC · Jul 3, 2006
- K050051 — ARMAND ENDOSCOPE HOLDER · KLS-Martin L.P. · May 16, 2005
- K093616 — V. MUELLER CAMERA CONTROLLER WITH STORAGE CART · Carefusion 2200 · Dec 23, 2009
Submission Summary (Full Text)
{0}------------------------------------------------
## K991989
AUG 27 1999
## 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of the Safe Medical Devices Act (SMDA) of 1990 and 21 CFR 807.92. All data included in this document is accurate and complete to the best of Mitaka's knowledge.
| Applicant: | Mitaka USA, Inc.<br>2337 Lucky John Drive<br>Park City, Utah 84060<br>(435) 649-2236 |
|------------------------|--------------------------------------------------------------------------------------|
| Contact: | Max Sturgis<br>President |
| Device Identification: | Common Name:<br>Endoscope Holder |
Trade Name: (optional) Point Setter
Indication: The Mitaka Point Setter is intended for use by qualified surgeons for holding rigid and flexible endoscopes during diagnostic and therapeutic neurologic procedures.
Device Description: The Mitaka Point Setter is a manual/pneumatic surgical device composed of materials commonly used in medical devices for a wide range of applications.
Substantial Equivalence: The Mitaka Point Setter is substantially equivalent to the predicate device since the basic features and intended uses are the same.
Signed:
Max Sturgis
President
{1}------------------------------------------------
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing right, with flowing lines representing hair or clothing.
Public Health Service
AUG 27 1999
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Max Sturgis President Mitaka USA, Inc. 2337 Lucky John Drive Park City, Utah 84060
Re: K991989 Trade Name: Mitaka Point Setter Regulatory Class: II Product Code: GWG Dated: June 7, 1999 Received: June 14, 1999
Dear Mr. Sturgis:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (OS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
{2}------------------------------------------------
Page 2 - Mr. Max Sturgis
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Mark N. Milkman
Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
## K 991989 510(k) Number (if known):
Device Name: Mitaka Point Setter
Indications for Use: This instrument is intended for use by qualified surgeons for holding rigid and flexible endoscopes during diagnostic and therapeutic neurologic procedures.
Mark N Mulkerron
for
(Division Sign-Off) Division of General Restorative Devices 510(k) Number ..
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use: OR Over-The-Counter Use: (Per 21 CFR 801.109)
(Optional Format 1-2-96)
ﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴﻴ
(99198